EGFR-IN-34 is a low-toxicity, acrylamide derivative antitumor agent that is a potent inhibitor of EGFR. Among others, overexpression and mutation of the epidermal growth factor receptor (EGFR) has been shown to lead to uncontrolled cell growth and is associated with the progression of most cancer diseases, especially NSCLC. EGFR-IN-34 exhibits potential for research in EGFR mutation-related diseases.
Molecular Weight:
490.98
Formula:
C26H27ClN6O2
Target:
Others|||EGFR
T63300
* VAT and and shipping costs not included. Errors and price changes excepted
